Anti-cyclic citrullinated peptide (Anti-CCP) and anti-mutated citrullinated vimentin (Anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Gonzalez Lopez, Laura ^a   Rocha Muñoz, Alberto Daniel ^b   Ponce Guarneros, Manuel ^a,c   Flores Chavez, Alejandra ^a   Salazar Paramo, Mario ^c   Nava, Arnulfo ^a   Cardona Muñoz, Ernesto German ^c   Fajardo Robledo, Nicte Selene ^a   Zavaleta Muñiz, Soraya Amali ^c   Garcia Cobian, Teresa ^c   Gamez Nava, Jorge Ivan ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Jalisco   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; MUTATED CITRULLINATED VIMENTIN ANTIBODY; PREDNISONE; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; VIMENTIN;

ADULT; AMYLOIDOSIS; ANEMIA; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BRONCHIOLITIS OBLITERANS; CERVICAL MYELOPATHY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; EXTRAARTICULAR MANIFESTATION RHEUMATOID ARTHRITIS; FELTY SYNDROME; FEMALE; GLOMERULONEPHRITIS; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORGANIZING PNEUMONIA; PERICARDITIS; PERIPHERAL NEUROPATHY; PLEURISY; RETINA VASCULITIS; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SCLERITIS; SJOEGREN SYNDROME; UVEITIS; VASCULITIS; XEROSTOMIA; AGED; ARTHRITIS, RHEUMATOID; BLOOD; COMPLICATION; IMMUNOLOGY; MIDDLE AGED; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VIMENTIN;

EID: 84900307881     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/536050     Document Type: Article

References (19)

1. Prete M., Racanelli V., Digiglio L., Vacca A., Dammacco F., Perosa F., Extra-articular manifestations of rheumatoid arthritis: an update. Autoimmunity Reviews 2011 11 123 131 2-s2.0-80053341974 10.1016/j.autrev.2011.09.001
2. Turesson C., Jacobsson L., Bergström U., Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology 1999 38 7 668 674 2-s2.0-0032753735 10.1093/rheumatology/38.7.668 (Pubitemid 29507338)
3. Turesson C., McClelland R. L., Christianson T. J. H., Matteson E. L., Multiple extra-articular manifestations are associated with poor survival in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2006 65 11 1533 1534 2-s2.0-33750319229 10.1136/ard.2006.052803 (Pubitemid 44629139)
4. Turesson C., Jacobsson L., Bergström U., Truedsson L., Sturfelt G., Predictors of extra-articular manifestations in rheumatoid arthritis. Scandinavian Journal of Rheumatology 2000 29 6 358 364 2-s2.0-0034539003 10.1080/030097400447552 (Pubitemid 32014835)
5. Weyand C. M., Xie C., Goronzy J. J., Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis. Journal of Clinical Investigation 1992 89 6 2033 2039 2-s2.0-0026654604
6. Taylor P., Gartemann J., Hsieh J., Creeden J., A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis. Autoimmune Diseases 2011 2011 18 815038 10.4061/2011/815038
7. Turesson C., Jacobsson L. T. H., Sturfelt G., Matteson E. L., Mathsson L., Rönnelid J., Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Annals of the Rheumatic Diseases 2007 66 1 59 64 2-s2.0-33845968788 10.1136/ard.2006.054445 (Pubitemid 46044861)
8. Korkmaz C., Us T., Kaşifoǧlu T., Akgün Y., Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Clinical Biochemistry 2006 39 961 965 (Pubitemid 44468211)
9. Poulsom H., Charles P. J., Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis. Clinical Reviews in Allergy and Immunology 2008 34 1 4 10 2-s2.0-49349091092 10.1007/s12016-007-8016-3
10. Sghiri R., Bouajina E., Bargaoui D., Harzallah L., Fredj H. B., Sammoud S., Ghedira I., Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis. Rheumatology International 2008 29 1 59 62 2-s2.0-53149087063 10.1007/s00296-008-0614-8
11. Turesson C., O'Fallon W. M., Crowson C. S., Gabriel S. E., Matteson E. L., Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. Journal of Rheumatology 2002 29 1 62 67 2-s2.0-0036138495 (Pubitemid 34041860)
12. Turesson C., O'Fallon W. M., Crowson C. S., Gabriel S. E., Matteson E. L., Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Annals of the Rheumatic Diseases 2003 62 8 722 727 2-s2.0-0038336741 10.1136/ard.62.8.722 (Pubitemid 36886405)
13. Swaak A., Anemia of chronic disease in patients with rheumatoid arthritis: aspects of prevalence, outcome, diagnosis, and the effect of treatment on disease activity. Journal of Rheumatology 2006 33 8 1467 1468 2-s2.0-33746763558 (Pubitemid 44168812)
14. Salinas M. J., Retamozo S., Vetorazzi L., Peano N., Cuiza P. E., Menescardi M. S., Miretti E. M., Encinas L. M., Alvarez A. C., Saurit V., Alvarellos A., Caeiro F., Anticitrulin antibody and the extra-articular manifestations in rheumatoid arthritis. Medicina: Buenos Aires 2013 73 21 25
15. Rojas-Villarraga A., Amaya-Amaya J., Rodriguez-Rodriguez A., Mantilla R. D., Anaya J. M., Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Disease 2012 2012 9 254319 10.1155/2012/254319
16. Barcelos F., Abreu I., Patto J. V., Trindade H., Teixeira A., Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome. Acta reumatológica portuguesa 2009 34 4 608 612 2-s2.0-79952112001
17. Ponce Guarneros J. M., Rocha Muñoz A. D., Gamez Nava J. I., Association between anti-cyclic citrullinated peptide antibodies titres and the presence and severity of diffuse interstitial lung disease secondary to rheumatoid arthritis. Arthritis & Rheumatology 2013 S175 S176
18. Mikuls T. R., O'Dell J. R., Stoner J. A., Parrish L. A., Arend W. P., Norris J. M., Holers V. M., Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody. Arthritis and Rheumatism 2004 50 12 3776 3782 2-s2.0-10444250299 10.1002/art.20659 (Pubitemid 39643924)
19. Nicaise Roland P., Grootenboer Mignot S., Bruns A., Hurtado M., Palazzo E., Hayem G., Dieudé P., Meyer O., Chollet Martin S., Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy. Arthritis Research & Therapy 2008 10 6 R142 2-s2.0-67949091264